We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
32 hedge funds and large institutions have $2.92M invested in CASI Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
7% more funds holding
Funds holding: 30 → 32 (+2)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
33% less capital invested
Capital invested by funds: $4.35M → $2.92M (-$1.43M)
Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$74.7K |
| 2 |
WJA
Williams Jones & Associates
New York
|
+$25.2K |
| 3 |
Renaissance Technologies
New York
|
+$22.4K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$17.4K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$5.17K |
Top Sellers
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
-$439K |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$27K |
| 3 |
WSC
Wellington Shields & Co
New York
|
-$21.5K |
| 4 |
EEG
E.E. Geduld
|
-$15.7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$47 |
